Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is associated with a number of chronic conditions such as cardiovascular and cerebrovascular diseases, type 2 diabetes and dyslipidemia and is a major cause of death.
The World Health Organization estimates that 10 % of the world’s adult population was obese in 2008. The global incidence of obesity is continuing to rise worldwide.
- Outstanding scientific expertise and consultancy
- Gold-standard methods and novel in-house techniques
- Dedicated research platform to evaluate the therapeutic potential of your compounds in obesity and other metabolic disorders and cardiovascular complications
- Customized research solutions to target your needs
Animal Experimental Models
Nutrional animal models
Diet-induced obese (DIO) mice (60% high fat diet, D12492)
Diet Induced Obesity (DIO) mouse (60% hig fat diet, D12492)
– for nutraceutical studies
Quickly evaluate the efficacy of your nutraceuticals on weight loss, glucose tolerance, insulin sensitivity and fatty liver.
Genetic animal models
A leptin-deficient mouse model to study diabetes, obesity and diabetic dyslipidemia.
Zucker Diabetic Fatty (ZDF) rat
A genetic rat model for the study of type 2 diabetes, hyperglycemia, insulin resistance, hyperinsulinemia, hypertriglyceridemia, hypercholesterolemia and cardiovascular or renal complications.
Zucker fatty rat
A genetic rat model of obesity, insulin resistance and hypertension.
|In vivo screening and profiling|
|Complementary techniques associated to diabetes and insulin resistance||Yes|
|Lipogenesis in vivo||Yes|
|Complementary techniques associated to lipid disorders||Yes|
|Non invasive imaging services|
|Body composition||Dual Energy X-Ray Absorptiometry (DEXA)|